Evoke plc (LON:EVOK – Get Free Report) shares dropped 10% during trading on Friday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the company. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th. Berenberg Bank reduced their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research report on Wednesday, December 4th.
View Our Latest Research Report on EVOK
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, equities research analysts expect that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling at Evoke
In other news, insider Andrea Gisle Joosen acquired 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
Evoke Company Profile
Featured Articles
- Five stocks we like better than Evoke
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 03/24 – 03/28
- The Most Important Warren Buffett Stock for Investors: His Own
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.